Artemis Investment Management LLP Buys Shares of 771,938 Ryan Specialty Holdings Inc. (NYSE:RYAN)

Artemis Investment Management LLP purchased a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 771,938 shares of the company's stock, valued at approximately $57,023,000. Artemis Investment Management LLP owned 0.29% of Ryan Specialty at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Rakuten Securities Inc. purchased a new position in Ryan Specialty in the fourth quarter worth about $27,000. Golden State Wealth Management LLC bought a new position in shares of Ryan Specialty in the 1st quarter worth approximately $35,000. Kapitalo Investimentos Ltda bought a new position in shares of Ryan Specialty in the 4th quarter worth approximately $36,000. Fifth Third Bancorp boosted its holdings in shares of Ryan Specialty by 202.5% in the first quarter. Fifth Third Bancorp now owns 484 shares of the company's stock worth $36,000 after buying an additional 324 shares during the last quarter. Finally, Principal Securities Inc. grew its position in Ryan Specialty by 164.7% during the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after buying an additional 415 shares during the period. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Up 0.3%

RYAN stock opened at $67.30 on Friday. The company has a market capitalization of $17.66 billion, a price-to-earnings ratio of 197.95, a PEG ratio of 1.79 and a beta of 0.70. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05. Ryan Specialty Holdings Inc. has a 1-year low of $55.67 and a 1-year high of $77.16. The business has a 50 day simple moving average of $68.28 and a two-hundred day simple moving average of $68.07.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. Ryan Specialty's revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.35 earnings per share. Research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.71%. Ryan Specialty's payout ratio is 141.18%.

Insider Transactions at Ryan Specialty

In related news, Director David P. Bolger sold 5,000 shares of the firm's stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the transaction, the director now directly owns 71,467 shares of the company's stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Mark Stephen Katz sold 14,377 shares of the company's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the sale, the executive vice president now directly owns 1,117 shares in the company, valued at approximately $73,543.28. The trade was a 92.79% decrease in their position. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on RYAN shares. Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Morgan Stanley raised their target price on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday, May 19th. Barclays lowered their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and upped their price target for the stock from $74.00 to $81.00 in a research report on Tuesday, May 13th. Finally, TD Cowen assumed coverage on Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of "Moderate Buy" and an average price target of $75.58.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.